Union Health Ministry Invites Stakeholder and Public Comments on Revised Draft National Pharmacy Commission Bill, 2026

1. At a Glance

• The National Pharmacy Commission (NPC) Bill, 2026 is a proposed legislation by the Ministry of Health and Family Welfare (MoHFW) to overhaul pharmacy regulation in India by replacing the Pharmacy Act, 1948 — a 78-year-old law. [1]
• It proposes to dissolve the existing Pharmacy Council of India (PCI) and replace it with a modern, multi-board commission structure analogous to the National Medical Commission (NMC) model.
• UPSC relevance: Tests governance of professional councils (GS-II), health policy reform, statutory body restructuring, and the broader NMC-model replication across healthcare professions.
• Revised draft released on 1 July 2026 after an earlier round of public consultations; stakeholder comments invited until 31 July 2026. [1]

2. Why in the News

• 1 July 2026: MoHFW uploaded a revised draft NPC Bill, 2026 on its website (mohfw-dohfw.gov.in) under the News and Highlights section, accompanied by a public notice seeking comments from the general public and stakeholders by 31 July 2026. [1]
• This revised draft follows examination of comments received during an earlier public consultation round, indicating the bill is in an advanced pre-legislative stage. [1]
• The move comes amid longstanding controversy around the Pharmacy Council of India (PCI) — including a CBI probe into PCI leadership — which reinvigorated demand for a new regulatory architecture.

3. Background & Evolution

• 1947: The Pharmacy Bill introduced in Parliament; assented on 4 March 1948, enacted as The Pharmacy Act, 1948 (Act 8 of 1948). [2]
• Rationale for 1948 Act: Prior to the Act, no restriction existed on practicing pharmacy in India; unqualified persons were compounding and dispensing medicines, posing public health risks. [2]
• 9 August 1949: Pharmacy Council of India (PCI) constituted under Section 3 of the Pharmacy Act, 1948 — India's apex statutory body for pharmacy education and practice regulation. [2]
• Subsequent decades: PCI regulated pharmacy education, maintained State Pharmacy Registers, and oversaw pharmacist registration through State Pharmacy Councils.
• 2023: Initial draft of the National Pharmacy Commission Bill circulated for stakeholder comments — the first systematic attempt to replace the 1948 Act.
• 2026: Revised draft released after incorporating earlier feedback; second round of public consultation opened. [1]
• Parallel reform context: The National Medical Commission Act, 2020 replaced the Medical Council of India; National Commission for Allied and Healthcare Professions Act, 2021 regulated allied health professionals — the NPC Bill continues this pattern of replacing old statutory councils with modern commission architectures.

4. Core Static Facts

Proposed NPC Structure (from draft bill):

• Chairperson + 14 part-time members + 13 ex-officio members

• Three autonomous Boards under NPC: 1. Pharmacy Education Board — regulates pharmacy education standards 2. Pharmacy Assessment and Rating Board — assesses and rates pharmacy institutions 3. Pharmacy Ethics and Registration Board — maintains National Pharmacy Register

• National Pharmacy Register: Centralised database of all registered pharmacy professionals

• Recognition of foreign pharmacy qualifications through application to the Commission

5. Multi-Dimensional Analysis

Legal / Constitutional

• The Pharmacy Act, 1948, operates under Entry 66 (coordination of professional standards), Union List, Schedule VII of the Constitution — giving Parliament the power to legislate on pharmacy education standards. [2]
• The NPC Bill, like the NMC Act, 2020, uses this concurrent legislative space while retaining state pharmacy councils for local registration.
• The Ethics and Registration Board introduces a statutory National Register — analogous to the National Medical Register under NMC — creating a single national database for the first time.
• Pre-legislative consultation model followed: draft circulated → public comments → revision → second consultation → introduction — in line with the Pre-Legislative Consultation Policy, 2014 of MoHFW.

Governance / Ethical

• PCI has faced repeated criticism for regulatory capture — dominated by pharmacy college interests rather than public health objectives; the NPC model attempts to break this by separating education, assessment, and ethics functions into distinct boards. [1]
• Mandatory public consultation (two rounds by mid-2026) reflects the pre-legislative scrutiny norm established post-FSSAI and NMC reforms.
• The separation of rating/assessment from regulation (distinct boards) mirrors best practices recommended by the Ranjit Roy Chaudhury Committee reports on medical education reform.
• Accountability: Under the proposed structure, the NPC reports to MoHFW — replacing the PCI's relatively autonomous functioning.

Social / Health Access

• India has approximately 12–15 lakh registered pharmacists across states, but quality of training is uneven; the NPC's Education Board aims to standardise curricula.
• Community pharmacists serve as first-contact healthcare providers for a large share of India's population, especially in rural areas where doctors are scarce — improving pharmacist quality directly impacts healthcare access.
• The National Pharmacy Register will help identify and address ghost registrations and unqualified practitioners operating in the informal sector.

Economic

• India's pharmaceutical retail market exceeds ₹1.8 lakh crore (world's 3rd largest by volume); robust pharmacist regulation is critical for patient safety in this market.
• Standardised pharmacy education (Pharmacy Education Board) is expected to improve export competitiveness of Indian pharma graduates and support the global pharmacy workforce.
• Recognition of foreign pharmacy qualifications creates a pathway for international pharmacist mobility, relevant given Indian diaspora's concentration in Gulf and UK health sectors.

Administrative

• State Pharmacy Councils will continue to exist for local registration under the new framework — Centre–State coordination required.
• Centre-State tension: Pharmacy education is on the Union List (Entry 66), but regulation of pharmacists practicing within states overlaps with state health (Entry 6, State List).
• Transition management: Existing PCI registrations, ongoing litigations, and institutional assets must be transferred — a complex administrative exercise that delayed similar transitions for MCI → NMC.

6. Recent Developments (Last 12–18 Months)

• 2025: Initial NPC Bill draft circulated for public consultation; wide stakeholder responses received from pharmacy associations, state councils, and academia.
• 2025: CBI investigation into the President of the Pharmacy Council of India for alleged irregularities — significantly raised urgency for structural reform of the PCI.
• 1 July 2026: Revised draft NPC Bill, 2026 uploaded by MoHFW on its official website after incorporating first-round public consultation feedback. [1]
• 1 July 2026: Public notice issued seeking further stakeholder/public comments by 31 July 2026. [1]
• Revised draft available in 5 regional languages (Urdu, Hindi, Gujarati, Tamil, Malayalam) to ensure inclusive consultation. [1]

7. Prelims Hooks (High-Density Factual Bullets)

1. The Pharmacy Act, 1948 was enacted on 4 March 1948 as Act 8 of 1948. [2]
2. The Pharmacy Council of India (PCI) was constituted on 9 August 1949 under Section 3 of the Pharmacy Act, 1948. [2]
3. The NPC Bill, 2026 proposes to repeal the Pharmacy Act, 1948 — the law it replaces is 78 years old. [1]
4. The revised draft NPC Bill, 2026 was released on 1 July 2026 by the Ministry of Health and Family Welfare. [1]
5. Stakeholder comments on the revised NPC Bill draft are due by 31 July 2026. [1]
6. NPC will have three autonomous boards: Pharmacy Education Board, Pharmacy Assessment and Rating Board, and Pharmacy Ethics and Registration Board.
7. The Pharmacy Ethics and Registration Board will maintain a centralised National Pharmacy Register.
8. NPC headquarters will be at New Delhi with 14 part-time members + 13 ex-officio members + a Chairperson.
9. The NPC Bill provides for recognition of pharmacy qualifications granted by institutions outside India through application to the Commission.
10. The NPC Bill is an initiative of MoHFW — not the Ministry of Chemicals and Fertilizers (which oversees the Drugs & Cosmetics Act).
11. The pre-legislative consultation model used here follows the Pre-Legislative Consultation Policy, 2014; this is the second round of public consultation (first round in 2023–25).
12. Pharmacy education regulation falls under Entry 66, Union List, Schedule VII of the Constitution (coordination of standards in higher/technical education).
13. The NPC Bill follows the structural template of the National Medical Commission (NMC) Act, 2020, which replaced the Medical Council of India.

8. Mains Relevance

GS Paper: GS-II (Governance, Constitution, Polity, Social Justice)

Specific Syllabus Headings:

• Government policies and interventions for development in various sectors and issues arising out of their design and implementation.
• Issues relating to development and management of Social Sector/Services relating to Health.
• Statutory, regulatory and quasi-judicial bodies.

Plausible Mains Question Stems:

1. The National Pharmacy Commission Bill, 2026 seeks to replace the Pharmacy Act, 1948. Critically examine the governance failures of the existing Pharmacy Council of India and assess whether the proposed commission model can address them. (250 words, GS-II)

2. The reform of professional councils in healthcare — from the Medical Council of India to the Pharmacy Council of India — reflects a broader shift in India's regulatory philosophy. Analyse this transition with reference to the principles of transparency, accountability and federal balance. (250 words, GS-II)

3. Discuss the significance of a National Pharmacy Register in the context of India's Universal Health Coverage goals. What administrative and legal challenges may arise in its implementation? (150 words, GS-II)

9. Related Topics to Study Next

1. National Medical Commission (NMC) Act, 2020 — Direct structural predecessor; NPC Bill mirrors NMC's three-board architecture; understanding NMC is essential for comparative analysis.
2. National Commission for Allied and Healthcare Professions (NCAHP) Act, 2021 — Covers physiotherapists, radiographers, and other allied health workers; part of the same wave of professional council reforms.
3. Pharmacy Council of India (PCI) — The body being dissolved; its statutory powers, composition, and failures are essential context.
4. Drugs and Cosmetics Act, 1940 — Regulates drug manufacture, sale, and import; intersects with pharmacy practice regulation; administered by a different ministry (Chemicals & Fertilizers for pharma, Health for drugs control).
5. Universal Health Coverage (UHC) and Ayushman Bharat — NPC's role in ensuring qualified pharmacists for primary health centres and Health and Wellness Centres.
6. Pre-Legislative Consultation Policy, 2014 — Procedural framework under which the NPC Bill's two-round consultation is being conducted.
7. Entry 66 vs. Entry 6 (Union/State List) — Constitutional division of legislative competence between Centre and states on healthcare professions — a recurring exam theme.
8. National Medical Register (NMR) under NMC — Functional parallel to the proposed National Pharmacy Register; understanding NMR implementation challenges illuminates NPC risks.

10. Common Errors / Trap Areas

1. Ministry confusion: The NPC Bill is under Ministry of Health and Family Welfare — NOT the Ministry of Chemicals and Fertilizers (which handles the pharma industry/NPPA/drug pricing) and NOT the Department of Pharmaceuticals.
2. Conflating PCI with the Drugs Controller: The Pharmacy Council of India regulates pharmacists and pharmacy education; the Central Drugs Standard Control Organisation (CDSCO) under DCGI regulates drug quality and licensing — entirely separate bodies with different enabling Acts.
3. Wrong year for Pharmacy Act: The Pharmacy Act was enacted on 4 March 1948 (Act 8 of 1948) — not 1940 (which is the Drugs and Cosmetics Act) and not 1947.
4. PCI constitution date: PCI was constituted 9 August 1949 (over a year after the Act was passed on 4 March 1948) — examinees often incorrectly state 1948 for PCI formation.
5. Three boards vs. NMC's four autonomous boards: NMC has four boards; the proposed NPC has three — confusing the two in comparative questions is a common trap.